U.S. Equities100d ago
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
Hims & Hers Health, Inc. stock rallied sharply today after the U.S. government confirmed it would reassess the regulatory framework for popular peptides, signaling a substantial expansion opportunity for the telehealth provider.